US Equity · NASDAQ · Earnings Dossier

DXCM earnings intelligence

DexCom Inc

Healthcare · Medical Devices · USD reporting basis

Current earnings profile Delivery strong, expectations demanding

Results have usually cleared estimates, but price has not consistently rewarded the delivery.

Evidence100/100 · Deep

Next scheduled catalyst

No forward date is currently stored

The historical dossier remains available while the next calendar date is unconfirmed.

0event risk

Inactive

Countdown-calendar proximity
EPS estimate-provider consensus
Estimate growth-versus comparable year-ago actual
Historical movement9.5%average absolute next weekly close

Three-year earnings transmission

Delivered earnings power versus market price

Earnings ahead

Earnings power is leading market price; the spread is stable and has persisted through 12 updates. Both series begin at 100, so the gap isolates the relative change in price and trailing earnings power.

Market move-20.1%2023-08-18 to 2026-08-07
Earnings move125.7%trailing diluted EPS
Unresolved spread145.7 ptsStable
Current multiple33.2xprice divided by TTM EPS
Relationship pressure89/100Extreme
Model confidence98/100High

Move decomposition

Earnings contribution and valuation offset

The market move is separated into the change in trailing earnings power and the offset from relative valuation.

Relationship controls

What qualifies the headline spread

Persistent earnings lead

Earnings power has led market price across several updates.

Business quality supportive

Cash generation and operating evidence are broadly supportive.

Beat rate83.3%10 beats in 12 measured quarters
Average surprise+11.9%median 9.7%
Delivery streak55 consecutive beats
Average response-3.3%12 measured reactions
Result-price confirmation33%same directional sign
Surprise variability14.5 ptspopulation dispersion

Estimate delivery

Actual EPS versus consensus

Actual and estimated EPS are displayed in reported currency on the same quarterly basis.

Price acceptance

Surprise and next weekly close

The response uses the first completed weekly close after the public report against the prior completed weekly close.

Fundamental delivery

Quarterly revenue and net income

Reported financial statements provide scale and earnings quality context around the headline EPS result.

Transmission matrix

Does price confirm delivery?

Upper right and lower left observations confirm the sign of delivery. The other quadrants expose expectation or resilience effects.

Current business context

Growth, quality and valuation

As of 9 Aug 2026
EPS growth74.9%year on year
Revenue growth15.5%year on year
Average surprise11.4%latest four quarters
SUE0.62standardised surprise
Net margin20.1%trailing basis
Cash conversion2.09xcash flow / net income
P/E32.0xcurrent snapshot
Data completeness100%alphavantage

Market context

Positioning into the event

Week ending 7 Aug 2026
Weekly close84.75 USDcompleted week
13-week return39.8%price momentum
Fair-value gap-1.9%price versus current fair value
Relative strength7.2exchange benchmark
Trend signalActiveweekly architecture
Next-week stateUndecided48.9%

Market context describes the setup surrounding the report. It does not convert the earnings event into a directional forecast.

Reported evidence ledger

Quarter-by-quarter delivery and acceptance

Each row preserves the reported estimate, public date, statement context and conservative weekly reaction measurement.

12 quarters
Reported / periodEPS actual / estimateSurpriseEPS growthRevenue / growthNext close / four weeksRead
Reported / period30 Jul 202630 Jun 2026 · exact
EPS actual / estimate0.70 / 0.61USD
Surprise+14.8%Beat
EPS growth+45.8%year on year
Revenue / growth1308400000+13.1% · USD
Next close / four weeks+16.6% / -completed weekly closes
ReadConfirmedresult versus price sign
Reported / period30 Apr 202631 Mar 2026 · exact
EPS actual / estimate0.56 / 0.47USD
Surprise+19.1%Beat
EPS growth+75.0%year on year
Revenue / growth1191900000+15.0% · USD
Next close / four weeks-0.4% / +17.1%completed weekly closes
ReadContainedresult versus price sign
Reported / period12 Feb 202631 Dec 2025 · exact
EPS actual / estimate0.68 / 0.65USD
Surprise+4.6%Beat
EPS growth+51.1%year on year
Revenue / growth1259600000+13.1% · USD
Next close / four weeks+0.1% / -2.7%completed weekly closes
ReadContainedresult versus price sign
Reported / period30 Oct 202530 Sep 2025 · exact
EPS actual / estimate0.61 / 0.57USD
Surprise+7.0%Beat
EPS growth+35.6%year on year
Revenue / growth1209300000+21.6% · USD
Next close / four weeks-17.2% / -14.4%completed weekly closes
ReadDivergedresult versus price sign
Reported / period30 Jul 202530 Jun 2025 · exact
EPS actual / estimate0.48 / 0.44USD
Surprise+9.1%Beat
EPS growth+11.6%year on year
Revenue / growth1157100000+15.2% · USD
Next close / four weeks-10.9% / -7.6%completed weekly closes
ReadDivergedresult versus price sign
Reported / period1 May 202531 Mar 2025 · exact
EPS actual / estimate0.32 / 0.33USD
Surprise-3.0%Miss
EPS growth0.0%year on year
Revenue / growth1036000000+12.5% · USD
Next close / four weeks+13.9% / +17.9%completed weekly closes
ReadDivergedresult versus price sign
Reported / period13 Feb 202531 Dec 2024 · exact
EPS actual / estimate0.45 / 0.50USD
Surprise-10.0%Miss
EPS growth-10.0%year on year
Revenue / growth1113500000+7.6% · USD
Next close / four weeks+1.1% / -11.6%completed weekly closes
ReadDivergedresult versus price sign
Reported / period24 Oct 202430 Sep 2024 · exact
EPS actual / estimate0.45 / 0.43USD
Surprise+4.7%Beat
EPS growth-10.0%year on year
Revenue / growth994200000+2.0% · USD
Next close / four weeks+1.5% / +4.8%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period25 Jul 202430 Jun 2024 · exact
EPS actual / estimate0.43 / 0.39USD
Surprise+10.3%Beat
EPS growth-year on year
Revenue / growth1004300000- · USD
Next close / four weeks-42.7% / -33.1%completed weekly closes
ReadDivergedresult versus price sign
Reported / period25 Apr 202431 Mar 2024 · exact
EPS actual / estimate0.32 / 0.27USD
Surprise+18.5%Beat
EPS growth-year on year
Revenue / growth921000000- · USD
Next close / four weeks-4.9% / +0.5%completed weekly closes
ReadDivergedresult versus price sign
Reported / period8 Feb 202431 Dec 2023 · exact
EPS actual / estimate0.50 / 0.43USD
Surprise+16.3%Beat
EPS growth-year on year
Revenue / growth1034500000- · USD
Next close / four weeks-0.4% / +0.6%completed weekly closes
ReadContainedresult versus price sign
Reported / period26 Oct 202330 Sep 2023 · exact
EPS actual / estimate0.50 / 0.33USD
Surprise+51.5%Beat
EPS growth-year on year
Revenue / growth975000000- · USD
Next close / four weeks+3.9% / +22.1%completed weekly closes
ReadConfirmedresult versus price sign

Reproducible method

How the earnings dossier is measured

Descriptive, not predictive
Estimate delivery

Reported diluted EPS is compared with the stored estimate for the same fiscal period. Moves within ±0.5% are classified as in-line.

Price response

The first completed weekly close after the public date is compared with the prior completed weekly close. Four-week response uses the first close at least 21 days later.

Event risk

Risk combines proximity, average absolute price movement, surprise variability, estimate availability and timing certainty. It does not score direction.

Data discipline

Exact public dates are used when stored. Missing estimates, timing and statement fields remain missing. No result or reaction is filled from a future observation.

Independent market research for education. Not investment advice, a recommendation, forecast, target or execution instruction.

Evidence context